Supplementary_tables: Prognostic implications of PD-L1 expression in patients with angiosarcoma
收藏DataCite Commons2024-05-18 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Supplementary_tables_Prognostic_implications_of_PD-L1_expression_in_patients_with_angiosarcoma/14636109
下载链接
链接失效反馈官方服务：
资源简介：
Background: There are limited data on the feasibility of
programmed death ligand-1 (PD-L1) expression as a prognostic biomarker in
metastatic angiosarcoma. Materials & Methods: We retrospectively collected
and analyzed the data on PD-L1 expression in 70 angiosarcoma patients who were
diagnosed at our center between 2005 and 2019. Results: Thirteen (19%) patients
had PD-L1 expression. Metastatic angiosarcoma patients who were PD-L1-negative
(n=24) showed longer median progression-free survival (4.9 vs. 1.6 months;
p=0.04) and median overall survival (OS; 10.9 vs. 5.4 months; p=0.01) than
those who were PD-L1-positive (n=4). PD-L1 status proved to be a significant
factor for OS. Conclusions: Metastatic angiosarcoma patients with PD-L1
expression showed shorter survival. PD-L1 status is an independent prognostic
factor for OS in metastatic angiosarcoma patients.
提供机构：
Taylor & Francis
创建时间：
2021-05-21
